Max L. Birnstiel
Affiliations: | Molecular Biology | Universität Zürich, Zürich, ZH, Switzerland |
Website:
http://www.imls.uzh.ch/aboutus/hof/cvmb.htmlGoogle:
"Max L. Birnstiel"Bio:
(1933 - 2014)
http://www.nasonline.org/member-directory/deceased-members/47084.html
http://dx.doi.org/10.3929/ethz-a-000150890
DOI: 10.1073%2Fpnas.1423755112
Mean distance: 10.03 | S | N | B | C | P |
Parents
Sign in to add mentor| Albert Frey-Wyssling | grad student | 1960 | ETH Zürich | |
| (Ueber das Redoxpotential lebender und absterbender Pflanzengewebe(Tabakverbräunung) ) | ||||
| James Frederick Bonner | post-doc | 1960-1963 | Caltech | |
Children
Sign in to add trainee| Adrian Bird | grad student | Edinburgh (Neurotree) | |
| Meinrad Busslinger | grad student | Universität Zürich (Neurotree) | |
| Michael Grunstein | grad student | Edinburgh | |
| Bernhard Luscher | grad student | Universität Zürich (Neurotree) | |
| Mary Lou Pardue | post-doc | (FlyTree) | |
| Walter Schaffner | post-doc | Universität Zürich (FlyTree) | |
| Stuart Gordon Clarkson | post-doc | 1970-1972 | Edinburgh |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fritz JH, Brunner S, Birnstiel ML, et al. (2004) The artificial antimicrobial peptide KLKLLLLLKLK induces predominantly a TH2-type immune response to co-injected antigens Vaccine. 22: 3274-3284 |
| Birnstiel ML. (2002) The dawn of gene isolation Gene. 300: 3-11 |
| Spinelli G, Birnstiel ML. (2002) The modulator is a constitutive enhancer of a developmentally regulated sea urchin histone H2A gene Bioessays. 24: 850-857 |
| Mattner F, Fleitmann JK, Lingnau K, et al. (2002) Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: Induction of potent and long-lasting T-cell responses against cancer antigens Cancer Research. 62: 1477-1480 |
| Cotten M, Baker A, Birnstiel ML, et al. (2001) Preparation of adenovirus-polylysine-DNA complexes. Current Protocols in Human Genetics / Editorial Board, Jonathan L. Haines ... [Et Al.]. Unit 12.3 |
| Birnstiel ML. (1999) Moving from Zurich to Vienna: Up or down? Biological Chemistry. 380: 111-112 |
| Schmidt W, Maass G, Buschle M, et al. (1997) Generation of effective cancer vaccines genetically engineered to secrete cytokines using adenovirus-enhanced transferrinfection (AVET). Gene. 190: 211-6 |
| Stingl G, Bröcker EB, Mertelsmann R, et al. (1997) Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Journal of Molecular Medicine (Berlin, Germany). 75: 297-9 |
| Schmidt W, Buschle M, Zauner W, et al. (1997) Cell-free tumor antigen peptide-based cancer vaccines Proceedings of the National Academy of Sciences of the United States of America. 94: 3262-3267 |
| Buschle M, Schmidt W, Zauner W, et al. (1997) Transloading of tumor antigen-derived peptides into antigen-presenting cells Proceedings of the National Academy of Sciences of the United States of America. 94: 3256-3261 |